NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 126 filers reported holding NUVATION BIO INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,797,788 | -25.5% | 32,684,916 | +0.0% | 0.00% | -20.0% |
| Q2 2023 | $58,807,004 | -45.8% | 32,670,558 | -50.0% | 0.01% | 0.0% |
| Q1 2023 | $108,466,000 | +113.0% | 65,340,964 | +146.3% | 0.01% | 0.0% |
| Q4 2022 | $50,931,773 | -23.8% | 26,526,965 | -11.1% | 0.01% | -28.6% |
| Q3 2022 | $66,862,000 | -35.3% | 29,849,463 | -6.4% | 0.01% | -30.0% |
| Q2 2022 | $103,308,000 | -37.8% | 31,885,031 | +0.9% | 0.01% | -23.1% |
| Q1 2022 | $166,208,000 | -38.2% | 31,598,727 | -0.2% | 0.01% | -35.0% |
| Q4 2021 | $269,161,000 | -15.7% | 31,666,040 | -1.4% | 0.02% | -20.0% |
| Q3 2021 | $319,375,000 | +8.0% | 32,130,174 | -1.6% | 0.02% | +8.7% |
| Q2 2021 | $295,669,000 | -5.0% | 32,647,471 | +1.1% | 0.02% | -14.8% |
| Q1 2021 | $311,213,000 | – | 32,284,495 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $120,756,000 | 24.71% |
| Aisling Capital Management LP | 2,541,009 | $13,366,000 | 7.21% |
| EDBI Pte Ltd | 1,270,504 | $6,683,000 | 4.45% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $5,981,000 | 4.43% |
| EcoR1 Capital, LLC | 13,896,543 | $73,096,000 | 2.29% |
| Boxer Capital, LLC | 4,341,009 | $22,834,000 | 1.17% |
| Baupost Group | 10,443,494 | $54,933,000 | 0.59% |
| Redmile Group, LLC | 3,471,709 | $18,261,000 | 0.57% |
| Avidity Partners Management LP | 4,855,006 | $25,537,000 | 0.53% |
| Abrams Capital Management | 3,811,513 | $20,049,000 | 0.47% |